Sopheon PLC
14 October 2002
FOR IMMEDIATE RELEASE 14 October 2002
SOPHEON PLC
PALL CORPORATION SELECTS SOPHEON'S ACCOLADE SOFTWARE
Leader in Filtration, Separations and Purification Industry Reports Sopheon's
Solution Key to Meeting Five-Year Business Goals
Sopheon plc ('Sopheon' LSE : SPE), an international provider of software and
services, announced today that Pall Corporation (NYSE: PLL) is implementing
Sopheon's Accolade product development software system as an integral part of
its five-year business plan. Pall, the world's pre-eminent filtration,
separation and purification products supplier, is planning a global deployment
that will initially involve 400 users in research and development, manufacturing
and marketing. The company said that it expects to see a return on its Accolade
investment in less than a year.
Pall will use Accolade to track, evaluate and prioritize hundreds of projects
based on key performance metrics so that resources are directed to projects with
the strongest revenue and profit potential while weaker concepts are eliminated
before major costs are incurred.
Andy Michuda, Chief Executive Officer of Sopheon, said :
'Pall is the latest prominent company in the materials science sector to choose
Accolade. This order is significant both because of its revenue value and the
fact that it signals Sopheon's continued penetration of a key target market.'
Sopheon's Accolade is the industry's first product development system that
integrates human-based decision-support services and process-enabling
technology. Accolade provides decision support throughout the product
development cycle, strengthening the process of generating ideas, accelerating
product creation and helping to ensure that resources are focused on the right
projects. According to Sopheon, the offering can improve time-to-market by as
much as 30 percent and cut product development spending waste in half.
For further information contact :
Barry Mence, Chairman Sopheon plc Tel : + 44 (0)1483-883000
Arif Karimjee, CFO Sopheon plc Tel : + 44 (0)1483-883000
Steve Liebmann Buchanan Communications Tel : + 44 (0)20-7466-5000
Barbara Jansen Citigate First Financial Tel : + 31 (0)205-754-010
About Sopheon
Sopheon is an international provider of software tools, experts and content that
help organizations improve the business impact of product development. Sopheon
serves nearly half of the technology-driven companies on the Fortune 500,
enabling higher, faster return on innovation and product development investments
through technology and human-based decision support. The company's products and
services include its flagship Accolade(R) product development system, the
award-winning Teltech.com(R) Web-based research portal for technical and
business professionals, and Organik(R) expertise-sharing software. Sopheon is
listed on the Alternative Investment Market of the London Stock Exchange and on
the Euronext in the Netherlands. For more information, please visit
www.sopheon.com.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.